Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00454376
What this trial is testing

Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
National Cancer Institute (NCI) 408
Early research (Phase 1)Study completedNCT02333188
What this trial is testing

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more
University of Chicago 50
Testing effectiveness (Phase 2)Study completedNCT03193190
What this trial is testing

Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

Who this might be right for
Pancreatic Adenocarcinoma
Hoffmann-La Roche 341
Testing effectiveness (Phase 2)Study completedNCT01016483
What this trial is testing

Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
EMD Serono 141
Not applicableEnded earlyNCT06290856
What this trial is testing

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

Who this might be right for
Metastatic Colorectal CancerPancreas AdenocarcinomaCholangiocarcinoma
Oslo University Hospital 16
Testing effectiveness (Phase 2)UnknownNCT06051851
What this trial is testing

Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 177
Not applicableUnknownNCT05848154
What this trial is testing

Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer

Who this might be right for
Patients With Non-metastatic Pancreatic CancerEvaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
Shanghai Zhongshan Hospital 92
Not applicableStudy completedNCT02374411
What this trial is testing

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

Who this might be right for
Pseudomyxoma PeritoneiAppendiceal NeoplasmsPancreatic Neoplasms+4 more
Edward Hospital 55
Early research (Phase 1)Ended earlyNCT05417386
What this trial is testing

FOLFIRINOX + NIS793 in Pancreatic Cancer

Who this might be right for
Pancreas CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Colin D. Weekes, M.D., PhD 4
Not applicableEnded earlyNCT00855634
What this trial is testing

Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München

Who this might be right for
Pancreatic Cancer
Technical University of Munich 355
Early research (Phase 1)Active Not RecruitingNCT00878163
What this trial is testing

GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmPancreatic Acinar Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT04115163
What this trial is testing

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Anne Noonan 67
Not applicableLooking for participantsNCT06046794
What this trial is testing

Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients

Who this might be right for
Cancer Of Pancreas
Institut Paoli-Calmettes 100
Early research (Phase 1)Looking for participantsNCT06126406
What this trial is testing

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+5 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07108504
What this trial is testing

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Shanghai Zhongshan Hospital 30
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Early research (Phase 1)Study completedNCT02231723
What this trial is testing

BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sumitomo Pharma America, Inc. 139
Testing effectiveness (Phase 2)Study completedNCT00005832
What this trial is testing

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 58
Testing effectiveness (Phase 2)Study completedNCT01543412
What this trial is testing

Second Line Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808567
What this trial is testing

Evaluation of the Efficacy and Safety of Neoadjuvant Therapy in Patients With Surgically Resectable Pancreatic Adenocarcinoma.

Who this might be right for
Pancreatic Adenocarcinoma ResectableNon MetastaticECOG Performance Status Score of 0 or 1
Gustave Roussy, Cancer Campus, Grand Paris 42
Next Page